Interestingly, in patients with ovarian cancer, both platelet count and serum TGF-β levels have been reported to be elevated, suggesting a possible correlation between platelet activity, TGF-β release, and tumor progression [93]. The gene discussed is TGFB1; the disease is ovarian cancer.